See more : Vicat S.A. (VCT.PA) Income Statement Analysis – Financial Results
Complete financial analysis of Universal Biosensors, Inc. (UBI.AX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Universal Biosensors, Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
- Volkswagen AG (VLKAF) Income Statement Analysis – Financial Results
- Daseke, Inc. Warrant (DSKEW) Income Statement Analysis – Financial Results
- Mirasol Resources Ltd. (0V7B.L) Income Statement Analysis – Financial Results
- Metronic Global Berhad (0043.KL) Income Statement Analysis – Financial Results
- PT Buana Artha Anugerah Tbk (STAR.JK) Income Statement Analysis – Financial Results
Universal Biosensors, Inc. (UBI.AX)
About Universal Biosensors, Inc.
Universal Biosensors, Inc., through its subsidiary, Universal Biosensors Pty Ltd, operates as a biosensors company primarily in Australia. The company focuses on the development, manufacture, and commercialization of point-of-use devices for measuring analytes across various industries. It manufactures and distributes Prothrombin Time International Normalized Ratio coagulation test strips; and distributes Siemens' Xprecia Stride Coagulation Analyzer, a test used to monitor the effect of the anticoagulant therapy warfarin. The company also manufactures and distributes Sentia SO2 test strips; and distributes Sentia Analyzer for the use in measurement of free SO2 levels in post-fermentation wine. In addition, it offers non-diagnostic laboratory services and performs coagulation testing services. The company has a license agreement with LifeScan Global Corporation to develop a biosensor strip and a meter to be used for the detection and monitoring of diabetes in animals. Universal Biosensors, Inc. was incorporated in 2001 and is headquartered in Rowville, Australia.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 6.63M | 4.52M | 5.78M | 3.20M | 6.90M | 69.46M | 25.19M | 18.83M | 16.77M | 9.53M | 15.09M | 29.65M | 14.73M | 18.18M | 22.04M | 4.56M | 1.29M | 2.65M |
Cost of Revenue | 2.35M | 2.39M | 3.67M | 2.58M | 3.57M | 2.51M | 3.95M | 1.15M | 1.38M | 555.83K | 11.64M | 18.66M | 13.02M | 8.67M | 627.40K | 3.12M | 2.33M | 0.00 |
Gross Profit | 4.28M | 2.14M | 2.11M | 623.09K | 3.33M | 66.95M | 21.24M | 17.68M | 15.39M | 8.97M | 3.45M | 10.99M | 1.71M | 9.51M | 21.42M | 1.44M | -1.04M | 2.65M |
Gross Profit Ratio | 64.60% | 47.27% | 36.44% | 19.46% | 48.22% | 96.38% | 84.32% | 93.88% | 91.77% | 94.17% | 22.84% | 37.07% | 11.60% | 52.33% | 97.15% | 31.50% | -80.22% | 100.00% |
Research & Development | 4.97M | 12.29M | 9.28M | 5.04M | 5.54M | 11.58M | 10.83M | 15.87M | 19.76M | 17.14M | 15.48M | 13.48M | 9.81M | 6.48M | 14.90M | 11.59M | 8.71M | 3.28M |
General & Administrative | 0.00 | 0.00 | 5.61M | 5.88M | 6.98M | 7.00M | 6.69M | 5.53M | 6.03M | 7.76M | 6.20M | 6.79M | 7.27M | 10.80M | 5.64M | 5.51M | 4.78M | 2.65M |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.80M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 105.77K | 0.00 |
SG&A | 15.17M | 10.98M | 5.61M | 5.88M | 6.98M | 7.00M | 6.69M | 5.53M | 6.03M | 7.76M | 6.20M | 6.79M | 7.27M | 10.80M | 5.64M | 5.51M | 4.78M | 2.65M |
Other Expenses | 817.94K | -2.06M | -1.79M | -574.09K | 1.21M | 577.51K | 122.34K | 7.68M | 8.30M | 9.00M | 6.92M | -256.50K | 30.44K | 33.01K | 250.89K | 1.13M | 946.86K | 0.00 |
Operating Expenses | 20.97M | 21.22M | 13.09M | 10.36M | 13.73M | 20.52M | 20.23M | 21.40M | 25.79M | 24.89M | 14.76M | 20.53M | 17.08M | 17.32M | 20.78M | 15.96M | 13.50M | 5.92M |
Cost & Expenses | 23.31M | 23.60M | 16.77M | 12.93M | 17.30M | 23.03M | 24.18M | 22.55M | 27.17M | 25.45M | 26.40M | 39.19M | 30.10M | 25.98M | 21.41M | 19.09M | 13.50M | 5.92M |
Interest Income | 734.38K | 381.60K | 49.95K | 293.82K | 825.94K | 491.04K | 172.38K | 201.10K | 242.57K | 260.90K | 499.97K | 437.17K | 683.32K | 1.19M | 809.46K | 2.54M | 1.56M | 488.20K |
Interest Expense | 177.39K | 18.15K | 121.91K | 154.80K | 0.00 | 2.99M | 2.80M | 2.90M | 2.37M | 2.66M | 819.77K | 29.26K | 0.00 | 0.00 | 9.64K | 9.49K | 0.00 | 0.00 |
Depreciation & Amortization | 969.67K | 2.79M | 2.57M | 2.43M | 1.51M | 2.11M | 2.59M | 2.65M | 2.70M | 2.51M | 2.50M | 2.64M | 30.44K | 2.99M | 809.46K | 2.54M | 594.53K | -146.46K |
EBITDA | -9.09M | -31.66M | -11.72M | -7.88M | -7.46M | 48.54M | 3.61M | -1.08M | -8.41M | -14.08M | -8.32M | -6.49M | -11.39M | -3.62M | 4.29M | -9.72M | -8.24M | -3.27M |
EBITDA Ratio | -137.05% | -352.96% | -150.54% | -222.73% | -141.95% | 70.02% | 13.53% | 22.05% | -50.12% | -69.83% | -71.67% | -30.70% | -104.40% | -42.92% | 6.53% | -263.02% | -943.39% | -123.20% |
Operating Income | -16.68M | -19.08M | -10.99M | -9.73M | -10.40M | 46.42M | 1.02M | -3.72M | -10.40M | -13.79M | -18.24M | -9.28M | -15.41M | -7.80M | 630.64K | -14.53M | -9.08M | -3.12M |
Operating Income Ratio | -251.48% | -421.63% | -190.17% | -303.88% | -150.78% | 66.84% | 4.03% | -19.77% | -61.98% | -144.66% | -120.86% | -31.31% | -104.61% | -42.92% | 2.86% | -318.80% | -701.56% | -117.69% |
Total Other Income/Expenses | 6.44M | 4.99M | 4.53M | 4.92M | 4.24M | -4.51M | -1.78M | 4.97M | 3.82M | 4.47M | 6.60M | 151.41K | 713.77K | 1.16M | 548.94K | 3.93M | 1.24M | 341.73K |
Income Before Tax | -10.24M | -29.91M | -10.51M | -7.64M | -6.16M | 41.92M | -764.72K | 1.25M | -6.58M | -9.32M | -11.63M | -9.13M | -14.69M | -6.61M | 1.43M | -12.00M | -8.55M | -2.78M |
Income Before Tax Ratio | -154.35% | -660.90% | -181.85% | -238.49% | -89.37% | 60.35% | -3.04% | 6.64% | -39.20% | -97.76% | -77.10% | -30.80% | -99.76% | -36.36% | 6.49% | -263.23% | -660.66% | -104.81% |
Income Tax Expense | -3.50M | -3.05M | -205.16K | 28.94K | -1.32M | 4.35M | 2.93M | 7.93M | 2.37M | 9.15M | 5.25M | -2.86M | -683.32K | -2.99M | 0.00 | -206.00 | -138.73K | 163.00K |
Net Income | -6.74M | -26.85M | -10.30M | -7.67M | -4.85M | 37.56M | -764.72K | 1.25M | -6.58M | -9.32M | -11.63M | -9.13M | -14.69M | -6.61M | 1.43M | -12.00M | -8.41M | -2.94M |
Net Income Ratio | -101.64% | -593.48% | -178.30% | -239.40% | -70.26% | 54.08% | -3.04% | 6.64% | -39.20% | -97.76% | -77.10% | -30.80% | -99.76% | -36.36% | 6.49% | -263.23% | -649.93% | -110.95% |
EPS | -0.03 | -0.14 | -0.06 | -0.04 | -0.03 | 0.21 | 0.00 | 0.01 | -0.04 | -0.05 | -0.07 | -0.06 | -0.09 | -0.04 | 0.01 | -0.08 | -0.06 | -0.06 |
EPS Diluted | -0.03 | -0.14 | -0.06 | -0.04 | -0.03 | 0.21 | 0.00 | 0.01 | -0.04 | -0.05 | -0.07 | -0.06 | -0.09 | -0.04 | 0.01 | -0.08 | -0.06 | -0.06 |
Weighted Avg Shares Out | 212.37M | 198.72M | 177.71M | 177.57M | 177.48M | 176.73M | 176.42M | 176.19M | 175.88M | 175.61M | 174.43M | 160.42M | 159.02M | 157.58M | 157.01M | 156.97M | 129.64M | 49.41M |
Weighted Avg Shares Out (Dil) | 212.37M | 198.72M | 177.71M | 177.57M | 177.48M | 177.15M | 176.42M | 177.37M | 175.88M | 175.61M | 174.43M | 160.42M | 159.02M | 157.58M | 161.35M | 156.97M | 129.64M | 49.41M |
Source: https://incomestatements.info
Category: Stock Reports